| First Author | Xu EE | Year | 2017 |
| Journal | Diabetes | Volume | 66 |
| Issue | 8 | Pages | 2213-2219 |
| PubMed ID | 28495880 | Mgi Jnum | J:249491 |
| Mgi Id | MGI:5923431 | Doi | 10.2337/db16-1074 |
| Citation | Xu EE, et al. (2017) SOX4 Allows Facultative beta-Cell Proliferation Through Repression of Cdkn1a. Diabetes 66(8):2213-2219 |
| abstractText | The high-mobility group box transcription factor SOX4 is the most highly expressed SOX family protein in pancreatic islets, and mutations in Sox4 are associated with an increased risk of developing type 2 diabetes. We used an inducible beta-cell knockout mouse model to test the hypothesis that Sox4 is essential for the maintenance of beta-cell number during the development of type 2 diabetes. Knockout of Sox4 at 6 weeks of age resulted in time-dependent worsening of glucose tolerance, impairment of insulin secretion, and diabetes by 30 weeks of age. Immunostaining revealed a decrease in beta-cell mass in knockout mice that was caused by a 39% reduction in beta-cell proliferation. Gene expression studies revealed that induction of the cell cycle inhibitor Cdkn1a was responsible for the decreased proliferation in the knockout animals. Altogether, this study demonstrates that SOX4 is necessary for adult beta-cell replication through direct regulation of the beta-cell cycle. |
